Molecular Imaging Can Detect Early Stages of Breast Cancer

The Society of Nuclear Medicine (SNM) has released new information about the role that molecular imaging had and will have on breast cancer detection. As October is U.S. National Breast Cancer Awareness Month, SNM decided to release this fact sheet during the Nuclear Medicine Week. It highlights the major features of molecular imaging on detecting this type of cancer in its earliest stage possible. The sooner the better, doctors always say, referring to cancer in particular.

 

Molecular imaging is actually a cheap and pain-free method of obtaining very detailed information about the structure and the functions that various cells undergo in the human body. Oncologists have long since emphasized their need for perfected tools with which to be able to detect all types of cellular anomalies at the earliest possible stage. With this technique, this could prove to be very easy and will bring closer doctors' ideal of personalized medicine. This concept refers to customizing medical services for each patient in particular, after analyzing individual fact sheets obtained via molecular imaging.

 

Doctors say that many lives could be saved by providing patients with the most appropriate treatment for their condition. In order for specialists to be able to make informed decisions, they should have the best possible equipment at their disposal. With molecular imaging, the need for exploratory surgery is completely eliminated, and the detection or confirmation of reoccurring cancerous cells is very simple. This investigative medical technique can be used often, with no health risks to patients, so as to monitor their progress over long periods of time. Regular checkups can help doctors identify any anomalous activities in the organism, and take immediate action to prevent any further damage to the cells.

 

According to SNM, molecular imaging is on its way to being implemented in all type of cancer detection procedures, on account of the reliable data it provides. Though it may be some time until viable programs are underway, the basic steps have already been taken and scientists working on the matter say that this field has been constantly developing over the past few years, at an incredible speed. How the medical system will look once this procedure becomes a standard part of medical tests in treating cancer remains to be seen.